P. Démolis

发表

Fruits , vegetables and lung cancer risk : a systematic review and meta-analysis

B. Jonsson, P. Foggi, F. Pignatti, 2015 .

Acetazolamide-induced vasodilation in the carotid vascular bed in healthy volunteers.

S. Chalon, P. Démolis, J. Giudicelli, 1995, Journal of cardiovascular pharmacology.

Evolution of the postoperative pericardial effusion after day 15: the problem of the late tamponade.

F. Larrazet, J. Tabet, P. Meurin, 2004, Chest.

Effects of an Angiotensin‐Converting Enzyme Inhibitor, Lisinopril, on Cerebral Blood Flow Autoregulation in Healthy Volunteers

C. Carville, P. Démolis, J. Giudicelli, 1993, Journal of cardiovascular pharmacology.

The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma.

N. Bolli, P. L. Bergsagel, M. Pasquini, 2021, Transplantation and cellular therapy.

Validation of multiple biomarkers: Regulatory expectations

P. Démolis, 2007 .

Vascular reactivity in acromegalic patients: preliminary evidence for regional endothelial dysfunction and increased sympathetic vasoconstriction

P. Chanson, P. Maison, J. Giudicelli, 2000, Clinical endocrinology.

Oncology clinical trials

P. Müller, T. Lai, G. Rosner, 2013 .

[Avoidable hospital drug prescription in the elderly. A review of the literature].

J. Ankri, D. Guillemot, O. Henry, 2002, Annales de medecine interne.

ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children.

W. Klapper, K. Norga, B. Burkhardt, 2019, European journal of cancer.

ACCELERATE and EMA Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children Authors

W. Klapper, K. Norga, B. Burkhardt, 2019 .

The European Medicines Agency review of cabazitaxel (Jevtana®) for the treatment of hormone-refractory metastatic prostate cancer: summary of the scientific assessment of the committee for medicinal products for human use.

E. Abadie, R. Hemmings, F. Pignatti, 2012, The oncologist.

How can biomarkers become surrogate endpoints

M. Scheulen, P. Démolis, B. Berns, 2007 .

Systemic, regional and cerebral hemodynamic effects of a new angiotensin converting enzyme inhibitor, imidapril, in healthy volunteers

P. Démolis, J. Giudicelli, P. Duhazé, 1994, Fundamental & clinical pharmacology.

The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.

C. Gisselbrecht, D. Bowen, F. Pignatti, 2016, The oncologist.

The European Medicines Agency approval of ingenol mebutate (Picato) for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use (CHMP)

J. Gardette, R. Hemmings, F. Pignatti, 2014, European Journal of Dermatology.

[Validation of Oscillomat, a device for self-measurement of blood pressure. Comparison with mercury sphygmomanometers].

J. Ménard, M. Safar, R. Asmar, 1991, Presse medicale.

Systemic and regional hemodynamics assessment in rats with fluorescent microspheres.

M. Gervais, J. Giudicelli, P. Démolis, 1999, Journal of cardiovascular pharmacology.

Effects of an angiotensin converting enzyme inhibitor, ramipril, on intracranial circulation in healthy volunteers

P. Démolis, S. Chalon, J. Giudicelli, 2006 .

Effects of an angiotensin converting enzyme inhibitor, ramipril, on intracranial circulation in healthy volunteers. off.

S. Chalon, P. Démolis, J. Giudicelli, 1992, British journal of clinical pharmacology.

ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients.

A. Jenkner, K. Norga, Martha Donoghue, 2020, European journal of cancer.

Comparative pharmacokinetics and pharmacodynamics of intravenous and oral nefopam in healthy volunteers.

P. Lechat, B. Diquet, J. Giudicelli, 2003, Pharmacology & toxicology.

Sensitive determination of nefopam and its metabolite desmethyl-nefopam in human biological fluids by HPLC.

I. Laville, B. Diquet, P. Démolis, 2002, Journal of pharmaceutical and biomedical analysis.

Is the acetazolamide test valid for quantitative assessment of maximal cerebral autoregulatory vasodilation? An experimental study.

N. Alkayed, J. Seylaz, G. Florence, 2000, Stroke.

Early market access of cancer drugs in the EU.

B. Jonsson, P. Foggi, D. Bowen, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Metoclopramide treatment in DBA patients: no complete response in a French prospective study.

L. D. Da Costa, T. Leblanc, I. Marie, 2007, Blood.

Comparative validation of the growth hormone-releasing hormone and arginine test for the diagnosis of adult growth hormone deficiency using a growth hormone assay conforming to recent international recommendations.

P. Chanson, J. Souberbielle, F. Borson‐Chazot, 2010, The Journal of clinical endocrinology and metabolism.

The European Medicines Agency Review of Carfilzomib for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy

J. Bergh, C. Gisselbrecht, E. Laane, 2017, The oncologist.

Identifying and preventing adverse drug events in elderly hospitalised patients: A randomised trial of a program to reduce adverse drug effects

L. Becquemont, P. Démolis, C. Trivalle, 2009, The journal of nutrition, health & aging.

The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use.

J. Emmerich, T. Salmonson, M. Haas, 2017, Sleep medicine.

Non-invasive evaluation of the conduit function and the buffering function of large arteries in man.

M. Safar, R. Asmar, R. Asmar, 1991, Clinical physiology.

Blood flow acceleration in the carotid and brachial arteries of healthy volunteers: respective contributions of cardiac performance and local resistance

D. Chemla, Y. Lecarpentier, P. Démolis, 1996, Fundamental & clinical pharmacology.

Repeatability of transcranial Doppler measurements of arterial blood flow velocities in healthy subjects.

S. Chalon, P. Démolis, J. Giudicelli, 1993, Clinical science.

Can a multi-stakeholder prioritisation structure support regulatory decision making? A review of paediatric oncology strategy forums reflecting on challenges and opportunities of this concept.

K. Norga, S. Galluzzo, R. Herold, 2020, Clinical pharmacology and therapeutics.

Relationships between cerebral regional blood flow velocities and volumetric blood flows and their respective reactivities to acetazolamide.

P. Démolis, J. Giudicelli, Y. T. Tran Dinh, 1996, Stroke.

Evolution of the postoperative pericardial effusion after day 15: the problem of the late tamponade.

F. Larrazet, J. Tabet, P. Meurin, 2004, Chest.